{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:05:06Z","timestamp":1790521506027,"version":"4.1.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Grant-in-Aid for Young Scientists","award":["17K15503"],"award-info":[{"award-number":["17K15503"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/toxsci\/kfz088","type":"journal-article","created":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T11:07:57Z","timestamp":1554635277000},"page":"95-108","source":"Crossref","is-referenced-by-count":14,"title":["Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats"],"prefix":"10.1093","volume":"170","author":[{"given":"Fuhua","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[{"name":"Department of Molecular and Environmental Pathology, Institute of Health Biosciences, Tokushima University Graduate School, Tokushima 770-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"2019062605503894100_kfz088-B1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/acs.chemrestox.7b00048","article-title":"Evaluating the role of multidrug resistance protein 3 (MDR3) inhibition in predicting drug-induced liver injury using 125 pharmaceuticals","volume":"30","author":"Aleo","year":"2017","journal-title":"Chem. Res. Toxicol"},{"key":"2019062605503894100_kfz088-B2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2008.08.018","article-title":"Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS\/MS","volume":"873","author":"Alnouti","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci"},{"key":"2019062605503894100_kfz088-B3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J. Hepatol"},{"key":"2019062605503894100_kfz088-B4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cld.2013.07.015","article-title":"Drug-induced cholestasis","volume":"17","author":"Bhamidimarri","year":"2013","journal-title":"Clin. Liver Dis"},{"key":"2019062605503894100_kfz088-B5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"key":"2019062605503894100_kfz088-B6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.10.3.409","article-title":"FXR: A target for cholestatic syndromes?","volume":"10","author":"Cai","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"2019062605503894100_kfz088-B7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/toxsci\/kfx284","article-title":"Measures of BSEP inhibition in vitro are not useful predictors of DILI","volume":"162","author":"Chan","year":"2018","journal-title":"Toxicol. Sci"},{"key":"2019062605503894100_kfz088-B8","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: Regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res"},{"key":"2019062605503894100_kfz088-B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res"},{"key":"2019062605503894100_kfz088-B10","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J. Rare Dis"},{"key":"2019062605503894100_kfz088-B11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab. Dispos"},{"key":"2019062605503894100_kfz088-B12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.molmed.2011.05.010","article-title":"Bile acids and colon cancer: Solving the puzzle with nuclear receptors","volume":"17","author":"Degirolamo","year":"2011","journal-title":"Trends Mol. Med"},{"key":"2019062605503894100_kfz088-B13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.21160","article-title":"Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation","volume":"43","author":"Demeilliers","year":"2006","journal-title":"Hepatology"},{"key":"2019062605503894100_kfz088-B14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment. Pharmacol. Ther"},{"key":"2019062605503894100_kfz088-B15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2019062605503894100_kfz088-B16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2009","journal-title":"Gut"},{"key":"2019062605503894100_kfz088-B17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0022-2275(20)37196-0","article-title":"Cloning, expression, and chromosomal localization of mouse liver bile acid CoA: Amino acid N-acyltransferase","volume":"38","author":"Falany","year":"1997","journal-title":"J. Lipid Res"},{"key":"2019062605503894100_kfz088-B18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin. Pharmacol. Ther"},{"key":"2019062605503894100_kfz088-B19","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","article-title":"The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver","volume":"273","author":"Gerloff","year":"1998","journal-title":"J. Biol. Chem"},{"key":"2019062605503894100_kfz088-B20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14740338.2015.983071","article-title":"Drug safety assessment of oral formulations of ketoconazole","volume":"14","author":"Gupta","year":"2015","journal-title":"Expert Opin. Drug Saf"},{"key":"2019062605503894100_kfz088-B21","first-page":"E75","article-title":"Influence of hepatic taurine concentration on bile acid conjugation with taurine","volume":"232","author":"Hardison","year":"1977","journal-title":"Am. J. Physiol"},{"key":"2019062605503894100_kfz088-B22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbalip.2005.10.006","article-title":"Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: A comparison of human BSEP with rat Bsep","volume":"1738","author":"Hayashi","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"2019062605503894100_kfz088-B23","doi-asserted-by":"crossref","first-page":"51085","DOI":"10.1074\/jbc.M308321200","article-title":"Farnesoid X receptor activates transcription of the phospholipid pump MDR3","volume":"278","author":"Huang","year":"2003","journal-title":"J. Biol. Chem"},{"key":"2019062605503894100_kfz088-B24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/jn\/121.7.985","article-title":"Interaction of dietary protein differing in sulfur amino acid content and pectin on bile acid conjugation in immature and mature rats","volume":"121","author":"Ide","year":"1991","journal-title":"J. Nutr"},{"key":"2019062605503894100_kfz088-B25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"2019062605503894100_kfz088-B26","doi-asserted-by":"crossref","first-page":"G58","DOI":"10.1152\/ajpgi.00367.2007","article-title":"Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells","volume":"294","author":"Kagawa","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"2019062605503894100_kfz088-B27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/jpet.114.220491","article-title":"Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonists","volume":"352","author":"Kenna","year":"2015","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2019062605503894100_kfz088-B28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2000-9426","article-title":"Hepatic transport of bile salts","volume":"20","author":"Kullak-Ublick","year":"2000","journal-title":"Semin. Liver Dis"},{"key":"2019062605503894100_kfz088-B29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0016-5085(00)70425-2","article-title":"Expression of the bile salt export pump is maintained after chronic cholestasis in the rat","volume":"118","author":"Lee","year":"2000","journal-title":"Gastroenterology"},{"key":"2019062605503894100_kfz088-B30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev"},{"key":"2019062605503894100_kfz088-B31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0016-5085(84)80021-9","article-title":"Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases","volume":"86","author":"Lewis","year":"1984","journal-title":"Gastroenterology"},{"key":"2019062605503894100_kfz088-B32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv. Pharmacol"},{"key":"2019062605503894100_kfz088-B33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03602532.2012.740048","article-title":"Nuclear receptors in bile acid metabolism","volume":"45","author":"Li","year":"2013","journal-title":"Drug Metab. Rev"},{"key":"2019062605503894100_kfz088-B34","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am. J. Pathol"},{"key":"2019062605503894100_kfz088-B35","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.510260641","article-title":"Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver","volume":"26","author":"Meier","year":"1997","journal-title":"Hepatology"},{"key":"2019062605503894100_kfz088-B36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.physiol.64.082201.100300","article-title":"Bile salt transporters","volume":"64","author":"Meier","year":"2002","journal-title":"Annu. Rev. Physiol"},{"key":"2019062605503894100_kfz088-B37","doi-asserted-by":"crossref","first-page":"G159","DOI":"10.1152\/ajpgi.00360.2003","article-title":"Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump","volume":"288","author":"Mita","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"2019062605503894100_kfz088-B38","doi-asserted-by":"crossref","first-page":"e005.","DOI":"10.1621\/nrs.08005","article-title":"Deciphering the nuclear bile acid receptor FXR paradigm","volume":"8","author":"Modica","year":"2010","journal-title":"Nucl. Recept. Signal."},{"key":"2019062605503894100_kfz088-B39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol. Sci"},{"key":"2019062605503894100_kfz088-B40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"2019062605503894100_kfz088-B41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann. Intern. Med"},{"key":"2019062605503894100_kfz088-B42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kft197","article-title":"Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11)","volume":"136","author":"Pedersen","year":"2013","journal-title":"Toxicol. Sci"},{"key":"2019062605503894100_kfz088-B43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/hep.21528","article-title":"Human and rat bile acid-CoA: Amino acid N-acyltransferase are liver-specific peroxisomal enzymes: Implications for intracellular bile salt transport","volume":"45","author":"Pellicoro","year":"2007","journal-title":"Hepatology"},{"key":"2019062605503894100_kfz088-B44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-011613-140021","article-title":"Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics","volume":"54","author":"Pfeifer","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"2019062605503894100_kfz088-B45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0034-1375962","article-title":"Drug-induced liver injury and drug development: Industry perspective","volume":"34","author":"Regev","year":"2014","journal-title":"Semin. Liver Dis"},{"key":"2019062605503894100_kfz088-B46","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus","volume":"276","author":"Riddle","year":"2001","journal-title":"J. Biol. Chem"},{"key":"2019062605503894100_kfz088-B47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2014.03.050","article-title":"Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury","volume":"147","author":"Robles-Diaz","year":"2014","journal-title":"Gastroenterology"},{"key":"2019062605503894100_kfz088-B48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.113.054205","article-title":"Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: Mechanistic considerations beyond the direct inhibition of the bile salt export pump","volume":"42","author":"Rodrigues","year":"2014","journal-title":"Drug Metab. Dispos"},{"key":"2019062605503894100_kfz088-B49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)32126-X","article-title":"Cholestasis: Human disease and experimental animal models","volume":"2","author":"Rodriguez-Garay","year":"2003","journal-title":"Ann. Hepatol"},{"key":"2019062605503894100_kfz088-B50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem"},{"key":"2019062605503894100_kfz088-B51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"2019062605503894100_kfz088-B52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"2019062605503894100_kfz088-B53","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-2275(20)32022-8","article-title":"Subcellular organization of bile acid amidation in human liver: A key issue in regulating the biosynthesis of bile salts","volume":"41","author":"Solaas","year":"2000","journal-title":"J. Lipid Res"},{"key":"2019062605503894100_kfz088-B54","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ijo.2016.46","article-title":"Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: A comparative study between rats, pigs and humans","volume":"40","author":"Spinelli","year":"2016","journal-title":"Int. J. Obes. (Lond.)"},{"key":"2019062605503894100_kfz088-B55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI116546","article-title":"Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium","volume":"92","author":"Spivey","year":"1993","journal-title":"J. Clin. Invest"},{"key":"2019062605503894100_kfz088-B56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/03602530903492004","article-title":"Role of the bile salt export pump, BSEP, in acquired forms of cholestasis","volume":"42","author":"Stieger","year":"2010","journal-title":"Drug Metab. Rev"},{"key":"2019062605503894100_kfz088-B57","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"2019062605503894100_kfz088-B58","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.xphs.2017.03.023","article-title":"Model systems for studying the role of canalicular efflux transporters in drug-induced cholestatic liver disease","volume":"106","author":"Stieger","year":"2017","journal-title":"J. Pharm. Sci"},{"key":"2019062605503894100_kfz088-B59","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-8278(86)80495-0","article-title":"Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases","volume":"3","author":"Stricker","year":"1986","journal-title":"J. Hepatol"},{"key":"2019062605503894100_kfz088-B60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1139\/o69-133","article-title":"Secretion of bile salts by intact and isolated rat livers","volume":"47","author":"Subbiah","year":"1969","journal-title":"Can. J. Biochem"},{"key":"2019062605503894100_kfz088-B61","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1086\/381444","article-title":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors","volume":"38","author":"Sulkowski","year":"2004","journal-title":"Clin. Infect. Dis"},{"key":"2019062605503894100_kfz088-B62","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid Res"},{"key":"2019062605503894100_kfz088-B63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/14728222.2016.1102889","article-title":"Recent advances in the exploration of the bile salt export pump (BSEP\/ABCB11) function","volume":"20","author":"Telbisz","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"2019062605503894100_kfz088-B64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: Molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol. Rev"},{"key":"2019062605503894100_kfz088-B65","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00204-018-2201-4","article-title":"In vitro prediction of drug-induced cholestatic liver injury: A challenge for the toxicologist","volume":"92","author":"Vinken","year":"2018","journal-title":"Arch. Toxicol"},{"key":"2019062605503894100_kfz088-B66","first-page":"491","article-title":"Inhibition of osteoblast differentiation by ritonavir","volume":"9","author":"Wakabayashi","year":"2018","journal-title":"Biomed. Rep"},{"key":"2019062605503894100_kfz088-B67","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","article-title":"Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2019062605503894100_kfz088-B68","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.110.067256","article-title":"Itraconazole-induced cholestasis: Involvement of the inhibition of bile canalicular phospholipid translocator MDR3\/ABCB4","volume":"79","author":"Yoshikado","year":"2011","journal-title":"Mol. Pharmacol"},{"key":"2019062605503894100_kfz088-B69","doi-asserted-by":"crossref","first-page":"31441","DOI":"10.1074\/jbc.M200474200","article-title":"Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem"},{"key":"2019062605503894100_kfz088-B70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/toxsci\/kfx060","article-title":"In vitro drug-induced liver injury prediction: Criteria optimization of efflux transporter IC50 and physicochemical properties","volume":"157","author":"Yucha","year":"2017","journal-title":"Toxicol. Sci"},{"key":"2019062605503894100_kfz088-B71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2016.03.019","article-title":"Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse","volume":"255","author":"Zhang","year":"2016","journal-title":"Chem. Biol. Interact"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfz088\/28540998\/kfz088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/170\/1\/95\/28864813\/kfz088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:55:26Z","timestamp":1663242926000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/170\/1\/95\/5460239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,4,12]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfz088","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,4,12]]}}}